The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of Patent Dispute

25 Mar 2010 12:30

RNS Number : 1650J
Intercede Group PLC
25 March 2010
 



25 March 2010

Intercede Group plc

("Intercede")

Settlement of Patent Litigation Between ActivIdentity and Intercede

Legal Action Terminated in California and UK

Highlights:

·; Intercede announces settlement of patent infringement disputes in the U.S. and the UK

 

·; The parties have settled the U.S. and UK litigations on mutually acceptable terms

 

London, United Kingdom 25 March 2010 - Intercede today announce that they have settled on mutually acceptable terms a lawsuit filed by ActivIdentity in the Northern District of California on 1 October 2008, and a lawsuit filed by Intercede in the UK High Court on 22 December 2009. 

The settlement entered on 23 March 2010 resolves patent litigation brought by ActivIdentity accusing Intercede's MyID products and Intercede's counterclaims alleging invalidity, violations of US antitrust law, fraud and unfair competition. This settlement includes a patent license, and the details of the settlement are confidential.

Richard Parris, Intercede's Chairman and Chief Executive, said:

 "We are pleased to end all outstanding legal disputes between Intercede and ActivIdentity and look forward to progressing our business. This settlement ensures that Intercede's worldwide partners and customers can continue to benefit from our leading MyID Identity and Credential Management System with confidence."

Intercede will take a charge to the current financial year for all of the exceptional costs associated with the legal fees relating to this case. It is not anticipated that the patent license agreement will have a material impact on Intercede's current or future earnings.

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit http://www.intercede.com

 

ENQUIRIES

Intercede Group plc

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Tel. +44 (0)1455 558111

FinnCap

Clive Carver /Charles Cunningham - Corporate Finance

Joanna Weaving - Corporate Broking

Tel. +44 (0)20 7600 1658

Pelham Public Relations

Archie Berens

Tel. +44 (0)20 7337 1509

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZFRKZGGZG
Date   Source Headline
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement
20th Dec 200511:29 amRNSDirector/PDMR Shareholding
15th Dec 20057:00 amRNSInterim Results
12th Dec 200512:28 pmRNSRe New OEM Agreement
9th Dec 200512:47 pmRNSHolding(s) in Company
30th Nov 200510:42 amRNSFurther re OEM Agreement
21st Nov 20051:44 pmRNSFurther re Global OEM Licence
12th Sep 20057:00 amRNSRe: Global OEM Licence
13th Jun 20054:12 pmRNSHolding(s) in Company-Amend
25th May 200512:04 pmRNSHolding(s) in Company
24th May 20057:00 amRNSFinal Results
31st Mar 20057:00 amRNSTrading Statement
24th Feb 200512:48 pmRNSRe Contract
21st Jan 20059:11 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.